Gastric Pull up Versus Free Flap Reconstruction for Laryngo-pharyngeal Defects
GPU vs ALT
1 other identifier
interventional
20
1 country
1
Brief Summary
This study will compare the gastric pull up (GPU) with the free flap \[(specifically, anterolateral thigh (ALT) and radial forearm free flap (RFFF)\] techniques used in the reconstruction of alimentary tracts in patients who require laryngectomy and circumferential pharyngectomy for carcinoma resection. These two interventions will be compared by block randomizing 20 patients based on history of failed chemoradiation to undergo either ALT or RFFF. The primary outcome will be the type and number of postoperative complications. The secondary outcomes will include swallowing function, speech, and quality of life measures along with cancer specific endpoints.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2017
CompletedStudy Start
First participant enrolled
March 16, 2017
CompletedFirst Posted
Study publicly available on registry
May 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedMay 31, 2017
May 1, 2017
5 years
February 22, 2017
May 30, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Type and number of postoperative complications
Complications will be divided by: (1) in-hospital mortality (2) reconstruction related complications (anastomotic leak, fistula formation, flap necrosis, flap stenosis or stricture, requirement for surgical revision), and (3) addition in-hospital complications ( bleeding, pulmonary, cardiac, infectious, abdominal, wound concern)
Within 90 days of surgery occurring on the same or separate admission.
Secondary Outcomes (16)
Surgical Time
Initial Surgery
Operative blood loss
Initial surgery
Operative Parameters
During initial surgery and within the first 72 hours.
Flap Donor Site Morbidity (RFFF) )
Measure documented at 1, 3, 6 and 12 months post-surgery, thereafter yearly for 5 years. (8 visits total)
Flap Donor Site Morbidity (ALT)
Measure documented at 1, 3, 6 and 12 months post-surgery, thereafter yearly for 5 years. (8 visits total)
- +11 more secondary outcomes
Study Arms (2)
Gastric Pull Up
EXPERIMENTALPatients randomized to undergo gastric pull up surgical reconstruction of pharyngoesophageal defect.
Free Flap
ACTIVE COMPARATORPatients randomized to undergo free flap (anterolateral thigh or radial forearm) surgical reconstruction of pharyngoesophageal defect.
Interventions
Using gastric tissue to reconstruct the esophagus and pharynx after pharyngo-esophagectomy.
Using radial forearm free flap or anterolateral thigh free flap to reconstruct the cervical esophagus and pharynx after pharyngectomy and cervical esophagectomy.
Eligibility Criteria
You may qualify if:
- Willing to provide informed consent, attend follow-up visits and complete questionnaires
- Have an Eastern Cooperation Oncology Group (ECOG) performance status of 0-2
- Patients with carcinoma of thyroid, larynx, hypopharynx, or cervical esophagus requiring surgery as a primary treatment modality or after chemoradiation treatment failure
- Laryngectomy and circumferential pharyngectomy as recommended by the head and neck tumor board
You may not qualify if:
- Serious medical co morbidities or other contraindications to surgery
- Metastatic disease
- Pregnant or lactating women
- Patients whose clinical circumstances are such that one surgical intervention would be recommended over the other: The cancer extends into the the thorax as seen on pre-operative CT scan. In these patients, the GPU reconstruction is preferred.
- Patients who have liver cirrhosis or multiple previous surgeries on the stomach would not be candidates for the GPU and thus will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prisman Eitan, MD, FRCSC
University of British Columbia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 22, 2017
First Posted
May 31, 2017
Study Start
March 16, 2017
Primary Completion
March 1, 2022
Study Completion
March 1, 2023
Last Updated
May 31, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers.